Načítá se...
Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis
PAI-1 has been shown to be both profibrotic and antifibrotic in animal models of hepatic fibrosis. Although these models have similarities to human fibrotic liver disease, no rodent model completely recapitulates the clinical situation; indeed, transaminase values in most models of hepatic fibrosis...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3095665/ https://ncbi.nlm.nih.gov/pubmed/21501583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.abb.2011.04.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|